2,470
Views
1
CrossRef citations to date
0
Altmetric
Special Report

Mayo Clinic: management of patients with statin intolerance

, &
Pages 541-549 | Published online: 18 Jan 2017
 

Abstract

Cardiovascular disease is the leading cause of death in the USA today. The role of lipid-lowering therapy to help reduce risks associated with primary and secondary prevention of coronary artery disease is at the forefront of treatment. The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or statins, have played a central role in the reduction of major adverse cardiac events, and are currently indicated for approximately 30 million people across the country. Although statins are generally well-tolerated, they are known to have myotoxic effects, ranging from self-limited muscle pain or cramping to rhabdomyolysis. Previous studies suggest 5–20% of patients on statin therapy will report such symptoms, often significant enough to prompt discontinuation of the medication. This review attempts to provide a framework for understanding statin intolerance by reviewing possible mechanisms, identifying patients at risk and discussing the preferred treatment approach utilized by the Mayo Clinic’s Statin Intolerance Clinic (MN, USA).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.